# Funding Strategy

## Lithium Orotate for Cognitive Protection Study

**Protocol**: LAHAI-LI-2026-001
**Document Version**: 1.0
**Date**: February 5, 2026

---

## Executive Summary

This document outlines the funding strategy for a 3-phase research program investigating low-dose lithium orotate for Alzheimer's disease prevention. The strategy leverages Lahai Health's non-profit status, partnerships with Verdant and other backers, and targeted grant applications to federal, foundation, and private sources.

### Funding Overview

| Phase | Duration | Budget Estimate | Primary Funding Sources |
|-------|----------|-----------------|-------------------------|
| Phase 1 Pilot | 12 months | $25,000 - $50,000 | Lahai/Verdant, foundations |
| Phase 2 Expansion | 18 months | $150,000 - $300,000 | Foundation grants, R21 |
| Phase 3 Validation | 24 months | $500,000 - $1,000,000 | NIH R01, industry partnership |

---

## Section 1: Organizational Funding Capacity

### 1.1 Lahai Health (Primary Sponsor)

**Status**: 501(c)(3) Non-Profit Organization
**Location**: 19820 Scriber Lake Rd, Suite #2, Lynnwood, WA 98036
**Phone**: (206) 363-4105
**Website**: [lahai.org](https://lahai.org)

**Verified Credentials**:
- âœ… 501(c)(3) tax-exempt status (Form 990 publicly available: 2022, 2023, 2024)
- âœ… NAFC Standards Seal Gold 2025 (National Association of Free & Charitable Clinics)
- âœ… Established 2003 (20+ years of operation)
- âœ… Carver Model of Policy Governance adopted June 2019

**Services**:
- Medical care (free/low-cost primary care in King & Snohomish Counties)
- Dental care (sliding fee scale)
- Mental health counseling (licensed professional counselors)

| Asset | Value to Funding |
|-------|------------------|
| Tax-exempt status | Eligible for foundation grants, tax-deductible donations |
| NAFC Gold certification | Demonstrates organizational quality and accountability |
| Community mission | Serves underserved â€” 500,000+ lack healthcare access in WA |
| Clinical infrastructure | Integrated medical, dental, and counseling services |
| PI relationships | Robert Deeble (Counseling Director) is Lahai staff |

**Executive Leadership Team**:
| Name | Title |
|------|-------|
| Maggie Konstanski | Executive Director |
| Candy McDonald, BSN | Medical Clinic Director |
| Molly Delamarter | Senior Development Director |
| Robert Deeble, LMHC | Counseling Director |
| Lily Lou, DMD | Managing Dentist |

**Board of Directors**:
| Role | Name | Credentials |
|------|------|-------------|
| President | Colin Eccles | â€” |
| Vice President | Bev Emerson | MBA |
| Secretary | Charlie LaNasa | CPA, Auditor Retired |
| Treasurer | Trent Theel | CPA |
| Member | Tom Burley | Strategic Advisor |
| Member | Peter Macharia | â€” |

**Potential Lahai Contributions**:
- In-kind PI time (Robert Deeble as Counseling Director)
- Administrative infrastructure (established 20+ years)
- Patient recruitment pipeline (serves King & Snohomish Counties)
- Seed funding from reserves (if board-approved)
- Access to volunteer network (200+ volunteers)

**Action Items**:
- [x] ~~Confirm Lahai Health 501(c)(3) status~~ âœ… Verified
- [ ] Present to Board of Directors for research program authorization
- [ ] Work with Molly Delamarter (Development) on funding strategy
- [ ] Establish research fund accounting codes

### 1.2 Verdant Health Commission (Established Funder)

**Relationship**: Existing financial supporter of Lahai Health
**Website**: [verdanthealth.org](https://verdanthealth.org)
**Status**: Verdant Health Commission logo appears on Lahai Health website as a supporting organization

**About Verdant Health Commission**:
Verdant Health Commission is a Washington State public hospital district (South Snohomish County Hospital District No. 2) that provides community health grants and programs. As a public entity, they fund community health initiatives in Snohomish County.

**Existing Relationship with Lahai**:
- Lahai Health is an established Verdant grantee/partner
- Logo displayed on Lahai website footer (recognized supporter)
- Geographic alignment: Both serve Snohomish County

**Potential Research Contributions**:
- Community health grant for cognitive health program
- Seed funding for Phase 1 pilot
- Matching funds for foundation grants
- Promotion through Verdant community channels

**Grant Considerations**:
| Factor | Assessment |
|--------|------------|
| Mission alignment | Strong â€” aging brain health is community health priority |
| Geographic fit | Strong â€” Serves South Snohomish County |
| Track record | Established â€” Lahai is existing grantee |
| Amount range | Likely $5,000-$50,000 (community grants) |

**Action Items**:
- [ ] Contact Verdant grants coordinator re: lithium/cognitive health project
- [ ] Prepare 2-page project summary for grant application
- [ ] Leverage existing Lahai-Verdant relationship
- [ ] Identify appropriate grant cycle and deadline

### 1.3 Other Private Backers

**Categories of Individual Donors**:

| Category | Approach | Ask Range |
|----------|----------|-----------|
| PI personal networks | Direct ask | $1,000 - $10,000 |
| Lahai Health donors | Newsletter/update | $100 - $5,000 |
| High-net-worth individuals | Cultivation events | $10,000 - $100,000 |
| Patient families | Invitation to support | $50 - $1,000 |

**Donor Cultivation Strategy**:
1. Create research program "Case for Support" document
2. Host informational webinar on lithium/AD research
3. Develop tiered recognition program
4. Provide regular updates to donors

---

## Section 2: Phase 1 Budget ($25,000 - $50,000)

### 2.1 Detailed Budget Estimate

| Category | Item | Unit Cost | Quantity | Total |
|----------|------|-----------|----------|-------|
| **Supplements** | | | | |
| | Lithium orotate (12 months) | $15/month | 30 Ã— 12 | $5,400 |
| | Contingency (overage, replacements) | | | $600 |
| **Subtotal** | | | | **$6,000** |
| **Laboratory** | | | | |
| | BMP panel | $25 | 30 Ã— 4 visits | $3,000 |
| | TSH | $20 | 30 Ã— 4 visits | $2,400 |
| **Subtotal** | | | | **$5,400** |
| **IRB & Regulatory** | | | | |
| | Commercial IRB (Sterling recommended) | $3,250 | 1 | $3,250 |
| | Amendments/continuing review | $500 | 2 | $1,000 |
| | Contingency | | | $750 |
| **Subtotal** | | | | **$5,000** |
| **Materials & Supplies** | | | | |
| | Cognitive assessment materials | $200 | 1 | $200 |
| | Office supplies, printing | $300 | 1 | $300 |
| | Data management (REDCap or equivalent) | $0-500 | 1 | $500 |
| **Subtotal** | | | | **$1,000** |
| **Personnel** | | | | |
| | Research coordinator (part-time) | $20/hr | 10 hrs/wk Ã— 52 | $10,400 |
| | Or: Coordinator stipend | Lump sum | | $5,000-10,000 |
| **Subtotal** | | | | **$5,000 - $10,400** |
| **Participant Incentives** | | | | |
| | Gift cards ($25 Ã— 4 visits) | $100 | 30 | $3,000 |
| **Subtotal** | | | | **$3,000** |
| **Contingency (10%)** | | | | **$2,500 - $3,100** |
| **TOTAL** | | | | **$27,900 - $33,900** |

> ðŸ“„ **See**: [IRB-SELECTION-GUIDE.md](IRB-SELECTION-GUIDE.md) for detailed IRB comparison and selection rationale. Lahai Health does not have an internal IRB.

### 2.2 Cost Reduction Options

| Option | Savings | Trade-off |
|--------|---------|-----------|
| University IRB affiliation | $3,000-4,000 | Requires faculty sponsor, slower |
| In-kind PI time | $5,000-10,000 | No direct salary support |
| Insurance-billed labs | $4,000-5,000 | Inconsistent coverage, participant cost |
| Free data tools (spreadsheets) | $500 | Less robust, more manual work |

**Minimum Viable Budget**: ~$15,000 (with maximum in-kind contributions)

---

## Section 3: Federal Funding Opportunities

### 3.1 NIH / National Institute on Aging (NIA)

**Primary Funding Institute**: NIA is the primary funder for Alzheimer's disease research

#### R21 Exploratory/Developmental Research Grant

| Parameter | Details |
|-----------|---------|
| **Mechanism** | R21 |
| **Budget** | Up to $275,000 over 2 years |
| **Purpose** | Exploratory/preliminary studies |
| **Fit** | Phase 1-2 feasibility and expansion |
| **Deadlines** | February, June, October (standard dates) |
| **Review Time** | ~6-9 months from submission |

**Strengths for Our Application**:
- Novel approach (lithium orotate vs. carbonate)
- Practice-based research setting (real-world evidence)
- Low-cost intervention with high public health impact
- Builds on strong mechanistic data (Nature 2025)

**Weaknesses to Address**:
- Non-academic setting (may need consultant statistician)
- Small pilot size
- Open-label design

**Action Items**:
- [ ] Identify program officer at NIA
- [ ] Request pre-submission consultation
- [ ] Develop specific aims draft

#### R01 Research Project Grant (Phase 3)

| Parameter | Details |
|-----------|---------|
| **Mechanism** | R01 |
| **Budget** | $500,000+ per year possible |
| **Purpose** | Definitive trials |
| **Fit** | Phase 3 multi-site RCT |
| **Timeline** | Apply after Phase 2 results |

### 3.2 NIA Relevant Funding Opportunity Announcements (FOAs)

> âš ï¸ **IMPORTANT**: FOAs listed below are from 2020-2024 and may be expired. **MUST verify current status** before citing in applications. Check [NIH Guide](https://grants.nih.gov/funding/searchguide/index.html) for active FOAs or successor programs.

| FOA | Focus | Relevance | Status (Feb 2026) |
|-----|-------|-----------|-------------------|
| PAR-23-057 | Alzheimer's Drug Development | High - repurposing existing compounds | âš ï¸ Verify expiration |
| PAR-22-093 | Pilot Clinical Trials for AD | High - early-phase trials | âš ï¸ Likely expired |
| PA-20-185 | Research on Informal and Formal Caregiving | Medium - if including caregiver outcomes | âš ï¸ Likely expired |
| NOT-AG-24-004 | AD research supplements | High - supplemental funding | âš ï¸ Notices short-lived |

**Action Items**:
- [ ] **URGENT**: Search NIH Guide for current Alzheimer's/MCI FOAs (before any grant work)
- [ ] Check for successor FOAs to expired programs (NIH often releases updated versions)
- [ ] Monitor NIH Guide monthly for new FOAs
- [ ] Register in eRA Commons (all PIs)
- [ ] Obtain DUNS/UEI number for Lahai Health
- [ ] Complete PI biosketches

### 3.3 Other Federal Sources

| Agency | Program | Fit |
|--------|---------|-----|
| PCORI | Patient-Centered Outcomes Research | Medium â€” comparative effectiveness angle |
| AHRQ | Practice-Based Research | Medium â€” implementation focus |
| DoD CDMRP | Alzheimer's Research Program | Low â€” typically focuses on veterans/TBI |

---

## Section 4: Foundation Funding Opportunities

### 4.1 Alzheimer's-Focused Foundations

#### Alzheimer's Drug Discovery Foundation (ADDF)

| Parameter | Details |
|-----------|---------|
| **Website** | alzdiscovery.org |
| **Funding Range** | $150,000 - $600,000 |
| **Duration** | 1-3 years |
| **Focus** | Drug development, repurposing, biomarkers |
| **Process** | Letter of Intent â†’ Full Proposal |
| **Deadlines** | Rolling (4-6 week LOI review) |

**Why This is a Strong Match**:
- ADDF specifically funds drug repurposing
- Lithium is an existing, safe compound
- Focus on early intervention aligns with their mission
- They funded Nature 2025 precursor work (Ludwig Foundation connection)

**Action Items**:
- [ ] Submit Letter of Intent
- [ ] Highlight Harvard/Yankner findings
- [ ] Emphasize cost-effectiveness vs. antibody drugs

#### Alzheimer's Association Research Grant

| Parameter | Details |
|-----------|---------|
| **Website** | alz.org/research |
| **Funding Range** | Up to $100,000 per year |
| **Duration** | 2-3 years |
| **Focus** | Broad AD research |
| **Deadline** | Annual (typically winter) |

**Action Items**:
- [ ] Review current funding priorities
- [ ] Identify best-fit grant mechanism
- [ ] Note: May prefer academic applicants

#### BrightFocus Foundation

| Parameter | Details |
|-----------|---------|
| **Website** | brightfocus.org |
| **Funding Range** | Up to $100,000 per year |
| **Duration** | 2 years |
| **Focus** | AD innovative research |
| **Deadline** | Annual |

### 4.2 Aging-Focused Foundations

| Foundation | Focus | Funding Range | Notes |
|------------|-------|---------------|-------|
| **Glenn Foundation for Medical Research** | Basic aging biology | $60,000/year | Funded Nature 2025 study |
| **American Federation for Aging Research (AFAR)** | Aging research | $100,000-200,000 | Various mechanisms |
| **Paul G. Allen Family Foundation** | Innovation | $100,000+ | Competitive, innovative focus |
| **Milken Institute** | Various health | Variable | Network cultivation |

### 4.3 Regional & Community Foundations

| Foundation | Location | Notes |
|------------|----------|-------|
| Local community foundation | New England | Smaller amounts, relationship-based |
| Health-focused family foundations | National | Research family giving databases |
| Rotary/Lions health grants | Local | $1,000-10,000 range |

**Action Items**:
- [ ] Research Foundation Directory (foundationcenter.org)
- [ ] Identify foundations with AD or aging focus
- [ ] Check geographic restrictions

---

## Section 5: Private & Industry Funding

### 5.1 Supplement Industry

**Caution**: Industry partnerships may create conflicts of interest

| Company Type | Potential Role | Concerns |
|--------------|----------------|----------|
| Lithium orotate manufacturers | In-kind supplement supply | Bias perception, quality control |
| Nootropic companies | Sponsorship | Commercialization pressure |
| Pharmaceutical (big pharma) | Unlikely for supplements | Not patentable |

**Recommendation**: Accept in-kind supplement donations only if:
- No control over study design or publication
- Full disclosure in protocol and publications
- Company meets quality/purity standards

### 5.2 Pharmaceutical Partnership (Future)

If Phase 2 shows positive results, pharmaceutical interest may develop:

| Scenario | Partner Type | Our Role |
|----------|-------------|----------|
| Formulation development | Pharma specializing in CNS | Provide clinical data, collaborate on IND |
| Label expansion | Generic lithium manufacturer | Academic partnership |
| Combination therapy | AD drug developer | Add-on study design |

---

## Section 6: Funding Timeline

### Year 1 (2026) - Phase 1 Funding

| Quarter | Activities | Target Funding |
|---------|------------|----------------|
| Q1 | Lahai/Verdant commitment, foundation research | $10,000-15,000 |
| Q2 | ADDF LOI submission, donor outreach | $10,000-20,000 |
| Q3 | Begin Phase 1, continue fundraising | Ongoing |
| Q4 | Interim data, foundation applications | R21 prep |

**Year 1 Target**: $30,000-50,000 (Phase 1 fully funded)

### Year 2 (2027) - Phase 1 Completion + Phase 2 Prep

| Quarter | Activities | Target Funding |
|---------|------------|----------------|
| Q1 | Phase 1 data collection | â€” |
| Q2 | R21 submission (October deadline for Q4) | â€” |
| Q3 | Phase 1 analysis, Phase 2 protocol | â€” |
| Q4 | Foundation applications for Phase 2 | $100,000-150,000 |

### Year 3+ (2028+) - Phase 2-3

| Phase | Timeline | Target Funding |
|-------|----------|----------------|
| Phase 2 Expansion | 2028 | $150,000-300,000 |
| Phase 3 Validation | 2029+ | $500,000-1,000,000 |

---

## Section 7: Grant Writing Resources

### 7.1 Required Documents

| Document | Status | Owner |
|----------|--------|-------|
| Lahai Health 501(c)(3) determination letter | â˜ Obtain | Lahai |
| Organization capability statement | â˜ Create | Fabio |
| PI biosketches (NIH format) | â˜ Create | All PIs |
| Current & pending support | â˜ Create | All PIs |
| Facilities & resources statement | â˜ Create | Fabio |
| Letter of support template | â˜ Create | Fabio |
| Budget justification template | â˜ Create | Fabio |

### 7.2 Grant Writing Support

| Resource | Cost | Notes |
|----------|------|-------|
| Consultant grant writer | $5,000-15,000 per application | Worth it for R01 |
| AI writing assistance | Free-low | Drafting, editing |
| NIH grant writing workshops | Free | NIA offers webinars |
| University partnership | Variable | Access to grants office |

### 7.3 Key Narrative Elements

Every grant application should address:

1. **Significance**: Why lithium for AD prevention matters
2. **Innovation**: Orotate form, practice-based setting, real-world evidence
3. **Approach**: Rigorous protocol based on prior RCTs
4. **Investigators**: Complementary expertise (clinical, medical, research)
5. **Environment**: Lahai Health infrastructure, patient access

---

## Section 8: Funder Cultivation Strategy

### 8.1 Relationship Building

| Funder Type | Strategy | Timeline |
|-------------|----------|----------|
| NIH Program Officers | Phone consultation, meeting at conferences | Q1-Q2 2026 |
| Foundation staff | LOI conversations, site visits | Q1-Q2 2026 |
| Verdant | Regular updates, board presentations | Ongoing |
| Individual donors | Personal outreach, events | Ongoing |

### 8.2 Communications Plan

| Audience | Communication | Frequency |
|----------|---------------|-----------|
| Active funders | Progress reports | Quarterly |
| Prospective funders | Research updates, publications | As available |
| Donor community | Newsletter, impact stories | Monthly |
| Scientific community | Presentations, publications | Ongoing |

---

## Section 9: Risk Mitigation

### 9.1 Funding Risks

| Risk | Likelihood | Mitigation |
|------|------------|------------|
| Phase 1 underfunded | Medium | Multiple small sources, reduced budget option |
| Foundation rejection | Medium | Apply to multiple foundations simultaneously |
| NIH competition | High | Strong preliminary data from Phase 1 |
| Funder conflict of interest concerns | Low | Transparent disclosures, diversified funding |

### 9.2 Backup Funding Options

| Scenario | Backup Plan |
|----------|-------------|
| No foundation grants | Extend private fundraising, reduce scope |
| Delayed NIH funding | Bridge with foundation/private funds |
| Phase 1 shows null results | Pivot to mechanism studies or combination approaches |

---

## Section 10: Action Items Summary

### Immediate (February 2026)

- [ ] Confirm Lahai Health grant eligibility (EIN, 501c3 letter)
- [ ] Schedule Verdant partnership discussion
- [ ] Begin PI biosketch preparation
- [ ] Research ADDF application requirements

### Short-term (March-April 2026)

- [ ] Submit ADDF Letter of Intent
- [ ] Complete Lahai board presentation for research authorization
- [ ] Develop donor cultivation list
- [ ] Register organization in grants.gov, eRA Commons

### Medium-term (May-August 2026)

- [ ] Finalize Phase 1 funding package
- [ ] Begin R21 specific aims development
- [ ] Cultivate NIH program officer relationship
- [ ] Launch donor outreach campaign

### Long-term (2027+)

- [ ] Submit R21 (October 2026 deadline for 2027 funding)
- [ ] Pursue Phase 2 foundation funding
- [ ] Develop industry partnership strategy (if Phase 1 positive)

---

## Appendix A: Funding Source Contact List

| Source | Contact | Website | Notes |
|--------|---------|---------|-------|
| NIH/NIA | [Program Officer TBD] | nia.nih.gov | Request consultation |
| ADDF | grants@alzdiscovery.org | alzdiscovery.org | LOI process |
| Alzheimer's Association | [Research grants] | alz.org | Annual deadline |
| BrightFocus | grants@brightfocus.org | brightfocus.org | AD program |
| Glenn Foundation | [TBD] | glennfoundation.org | Aging focus |
| AFAR | grants@afar.org | afar.org | Various mechanisms |

---

## Appendix B: Budget Justification Template

### Personnel

> **Research Coordinator (Part-time, 10 hours/week)**: Essential for participant scheduling, data collection, regulatory documentation, and study coordination. Rate based on local standards for research coordinator positions.

### Supplies

> **Lithium Orotate Supplements**: Study intervention for N=30 participants over 12 months. Cost reflects pharmaceutical-grade product with third-party purity testing.

### Other Costs

> **IRB Fees**: Commercial IRB review required as Lahai Health does not have an internal IRB. Sterling IRB is recommended based on cost-effectiveness and experience with supplement studies. See [IRB-SELECTION-GUIDE.md](IRB-SELECTION-GUIDE.md) for detailed comparison. Budget includes initial review, amendments, and continuing review.

> **Laboratory Testing**: Safety monitoring per protocol (BMP and TSH at baseline and three follow-up visits). Costs reflect non-insurance rates; actual costs may be lower if insurance covers routine labs.

> **Participant Incentives**: $25 gift card per in-person visit (4 visits) to compensate for time and travel. Standard practice for community-based research to support retention.

---

*Funding Strategy v1.0 â€” February 5, 2026*
*Review and update quarterly*
